Reneo Pharmaceuticals launches REN001 clinical trial in McArdle disease
Reneo Pharmaceuticals has initiated a phase 1b clinical trial of REN001 in glycogen storage disease type V (GSD V), also called McArdle disease. The California-based clinical-stage pharma company is currently enrolling participants into the early-stage clinical trial in the UK and Spain. Considered as an inherited disorder, McArdle disease is caused by the body’s inability […]